Long-term Outcomes Following Igrt For Localized Prostate Cancer: Dose Escalation To Spect/ct Determined Biologic Target Volumes And The Bdfs Predictive Value Of Capromab Pendetide

Title

Long-term Outcomes Following Igrt For Localized Prostate Cancer: Dose Escalation To Spect/ct Determined Biologic Target Volumes And The Bdfs Predictive Value Of Capromab Pendetide

Creator

Ellis R J; Kaminsky D A; Zhou E H; Fu P; Brelin A; Faulhaber P F; Bodner D

Publisher

International Journal of Radiation Oncology Biology Physics

Date

2009
2009

Subject

Nuclear Medicine & Medical Imaging; Oncology; Radiology

Format

Journal Article or Conference Abstract Publication

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

S45-S45

Issue

3

Volume

75

Citation

Ellis R J; Kaminsky D A; Zhou E H; Fu P; Brelin A; Faulhaber P F; Bodner D, “Long-term Outcomes Following Igrt For Localized Prostate Cancer: Dose Escalation To Spect/ct Determined Biologic Target Volumes And The Bdfs Predictive Value Of Capromab Pendetide,” NEOMED Bibliography Database, accessed January 16, 2021, https://neomed.omeka.net/items/show/9424.

Social Bookmarking